Adaptimmune Therapeutics (ADAP) - Shares outstanding

Number of shares outstanding as of December 2025 : 264,087,145

According to Adaptimmune Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 264,087,145. At the end of 2025 the company had 264,087,145 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Adaptimmune Therapeutics from 2014 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	0.26 B	3.25%
2024	0.25 B	13.02%
2023	0.22 B	37.89%
2022	0.16 B	5.06%
2021	0.15 B	0.93%
2020	0.15 B	47.18%
2019	0.10 B	0.57%
2018	0.10 B	11.62%
2017	93.68 M	32.35%
2016	70.78 M	0%
2015	70.78 M	-83.33%
2014	0.42 B

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Novavax NVAX	162,353,000	-38.52%	🇺🇸 USA
Enzo Biochem ENZB	52,403,000	-80.16%	🇺🇸 USA
uniQure QURE	58,516,415	-77.84%	🇳🇱 Netherlands
Exelixis EXEL	268,421,000	1.64%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Adaptimmune Therapeutics (ADAP)

Number of shares outstanding as of December 2025 : 264,087,145